Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study
Abstract Prevention of COVID-19 with vaccine requires multiple doses and updated boosters to maintain protection; however currently there are no tests that can measure immunity and guide clinical decisions about timing of booster doses. This study examined the association between the risk of COVID-1...
Main Authors: | Neeraj Sood, Chun Nok Lam, Eric Kawaguchi, Olivier Pernet, Andrea Kovacs, Jennifer B. Unger, Howard Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-47261-y |
Similar Items
-
Quantification of Severe Acute Respiratory Syndrome Coronavirus 2 Binding Antibody Levels To Assess Infection and Vaccine-Induced Immunity Using WHO Standards
by: Olivier Pernet, et al.
Published: (2023-02-01) -
Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
by: Disha Bhavsar, et al.
Published: (2023-12-01) -
Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
by: Birte Möhlendick, et al.
Published: (2022-06-01) -
Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
by: Tomohiro Takano, et al.
Published: (2023-03-01) -
High Levels of Anti-SARS-CoV-2 Receptor-Binding Domain (RBD) Antibodies One Year Post Booster Vaccinations among Hospital Workers in Indonesia: Was the Second Booster Needed?
by: Amila Hanifan Muslimah, et al.
Published: (2023-07-01)